Highly Respected Professionals and In-depth Experience
Since its establishment in 2000, Jipyong’s Capital Markets Group has leveraged its expertise to provide leading advisory services to various organizations in the capital markets sector, including to the Korea Financial Investment Association, the Financial Supervisory Service, the Korea Exchange, and the Korea Depository Receipts & Payments Corporation. We also have extensive experience representing underwriters issuers in various areas including,investments, GDR issuances, secondary listings and overseas listings in the domestic and international ECM sectors. Jipyong’s Capital Markets Group has assembled a dedicated team of professionals, including attorneys and various experts and advisors who formerly worked for the Korea Exchange and the Financial Supervisory Service, to provide clients with effective, practical legal services and solutions through organic collaboration with Jipyong’s other practice groups in criminal defense, pharmaceutical and biotechnology, IP and IT, financial litigation and ESG.
Domestic Capital Markets
Jipyong’s Capital Markets Group advises underwriters and issuers throughout the entire listing process including pre-listing preparations such as legal due diligence and establishment of internal control systems, responding to listing eligibility reviews and preparation of securities registration statements. We also advise on post-listing disclosures as well as fundraising and overseas expansion through paid-in capital increases and issuance of RCPS, CBs, etc. Jipyong’s Capital Markets Group has overwhelming strength in advising domestic companies on the Korea Exchange (KOSPI and KOSDAQ) and has been recognized as the IPO advisor with the highest number of advisory transactions in Korea for several years based on its demonstrated past successes and stellar reputation. In particular, we are active in advising on investments in artworks, real estate, vessels, etc. and STOs (Security Token Offering), which have been attracting notable attention recently.
Our Delisting Response Team, comprised of experts who were formerly in charge of delisting review and disclosures at the Korea Exchange, as well as our accountants and attorneys, effectively respond to delisting reviews of listed companies through organic cooperation with the PA teams of the target company's accounting firm. Since 2017, Jipyong’s Capital Markets Group has successfully advised corporate clients on delisting matters. Our clients include ChinHung International, STX, Borneo Furniture, Nanos, Mason Capital, MP Group, WI, Sehwa IMC, KD, Deco&E, Barun Electronics, Kyung Nam Pharmaceutical Healthcare, Kosen, and Good People. In addition, Jipyong’s Capital Markets Group includes advisors, attorneys and experts who have served as members of the Financial Services Commission, and advisors who have served as senior executives at the Financial Supervisory Service to provide a variety of administrative, criminal, and civil advisory services, including securities-related class action lawsuits and regulatory responses to unfair trade practices and market disruption. Jipyong’s Capital Markets Group also advises listed companies on ESG disclosures and corporate governance disclosures in collaboration with the ESG Center.
Jipyong’s Capital Markets Group regularly advises the Korea Exchange, the Korea Securities Depository Corporation, and the PEF Management Association as an advisory law firm and participated in the drafting of the Capital Markets and Financial Investment Business Act, as well as the preparation of the Listing Review Guidebook for IPOs published by the Korea Exchange. Based on the experiences and know-how gained through these activities, Jipyong’s Capital Markets Group advises clients to efficiently respond to changes in capital market regulations and trends.
Overseas Capital Markets
Jipyong’s Capital Markets Group provides comprehensive advice on international capital markets, including the listing of foreign companies and foreign holding companies (FHCs) on the Korean Exchange, the listing of Korean companies on overseas exchanges, and the issuance of DRs and bonds such as CBs and BWs. Jipyong’s Capital Markets Group successfully advised NewPride Corporation, the first U.S. company to be listed on the KOSDAQ, and has since advised OncoPep, Exbon, Bankcard Service and NeoImmuneTech in relation to their listings and establishment of disclosure systems. In addition, Jipyong’s Capital Markets Group has advised a number of companies in the ASEAN region on their listings in Korea. It successfully advised Kolao Holdings, the largest Korean trading company in the Lao PDR, on its listing on the Korea Exchange and the issuance of GDRs in Singapore; LS Cable & System Asia and Hwaseung Enterprise, both Vietnamese companies; and Prestige BioPharma, a Singaporean biosimilar company, on their listing on the Korea Exchange. It is currently advising NanoGen, the largest biosimilar company in Vietnam, on its listing on KOSDAQ. In addition, Jipyong’s Capital Markets Group advised various Korean companies including Mirae Industries, Shinhan Financial Holdings, NHN, Jinro, Mirinet Solar, and Doubledown Interactive on their listing on overseas exchanges or overseas tranche offerings, by working organically with other global law firms.
Furthermore, Jipyong's Capital Markets Practice has advised the Korea Exchange on its joint venture for the establishment of the securities exchanges in Cambodia and the Lao PDR, advised the underwriter for the IPO of various Cambodian state-owned enterprises and financial institutions in Cambodia, and successfully conducted research on the enactment of the Lao securities law and research on the development of the Cambodian stock market by collaborating with the Korea Exchange. Jipyong’s Capital Markets Group continues to strive to contribute to the development of international capital markets and expand exchanges through new challenges, and to provide more effective solutions to its clients based on the deep understanding of overseas capital markets.
Key Practice Areas Close
- Consulting services regarding legal due diligence, establishment of internal control systems, establishment of a disclosure system, and management control system
- Advising on fractional investing, securitization related to STOs and drafting securities report
- Preparation and negotiation of various declarations and contracts related to issuing domestic and foreign securities
- Listing of foreign companies in the Korean market (issuance of KDR through IPO)
- Public offering and listing of Korean companies in foreign stock markets and issuance of GDR
- Issuance of equity-linked securities such as CB, BW, RCPS
- Advising on the disclosure related to ESG and corporate governance report
- Advising on countermeasures to delisting examination
- Advising on countermeasures to corporate examination caused by adverse opinion of auditor
- Interpretation of laws related to the Financial Investment Services and Capital Market Act, development of new products, government relations regarding investor protection
- Disputes regarding unfair trade practices, violation of disclosure obligations and class action on securities
Experience Close
- Advised on the IPO of Korean companies including COTS Technology, FADU, MICUBE SOLUTION, ALT, GigaVis, S.Biomedics, Cell Bio Human Tech, Hanwha REIT, NanoTIM, Studio Mir, Samkee Ev, Hanjoo Light Metal, Enjet, Ubion, Yunsung F&C, JI Tech, Quality Reliability Technology, Plasmapp, Top Material, W Scope Chungju Plant, Laserssel, Dae Myoung Energy, 4by4, Yuil Robotics, Noul, VC, Incar Financial Service, Narae Nanotech Corporation, Assems, Auto& Inc., Raemongraein, Daol Investment (previously known as KTB Network), RBW, Dear U, NH All-One REIT, Enchem, GnBS Engineering, iFamilySC, ASFLOW, BioPlus, SK REIT, Abion, AJU Steel, LB Lusem, Jeju Beer, Genesystem, Samyoung S&C, IL SEUNG, CyberOne, Prestige Biologics, NANOCMS, Prestige Bio Pharma, Wider Planet, Rainbow Robotics, MOBIRIX Corporation, JR GLOBAL REIT, SK Biopharmaceuticals, Kakao Games Corporation, Precision Biosensor, Myoung Shin Industry, ABKO, NFC Corporation, NGeneBio, ENBIO, T&L, Solux, Brand X Corporation, YoungLimWon Soft Lab, Gencurix, Senko, Wonbang Tech, ILOODA, TSI, The Nature Holdings, Shindo ENG Lab, Lemon, PSK Holdings, Korea Pharma, Aptamer Sciences, P&K Skin Research Center, LOTTE REIT, OliPass Corporation, JLK, SettleBank, FirmTech, Suprema ID, SP Systems, Xi S&D, CTR Mobility (previously known as Central Motek Corp.), WOOYANG, Laon People, KNJ, THiRA-UTECH, E KOCREF CR-REIT, S-Fuelcell, SV Investment Corporation, Aju IB Investment, Newtree, iCure, T&R Biofab, CytoGen, Bifido, GenoFocus, Shinheung SEC, Dong Yang Piston, Haitai Confectionery and Foods, UGint, HISEM, FNC Entertainment, Jinro, SamwonSteel, PKvalve, Green Cross Medical Science Corp., JC Chemical
- Advised LVMC Holdings (former name: Kolao Holdings) on the issuance of USD 150 million GDRs and listing on the Singapore Exchange
- Advised Double Down Interactive and Mirinet Solar on their listing on NASDAQ
- Updated the NYSE business report (form 20-f) of Shinhan Financial Holdings and Mirae Corporation
- Represented Korea Exchange for its equity investment in Cambodia Exchange for a joint project between Korea and Cambodia
- Advised Korea Exchange on the establishment of securities exchanges in Cambodia and Laos
- Advised Cambodia’s state-owned Phonm Penh Water Authority and publicly-owned Phnom Penh Port Authority (PPAP) and ACLEDA Bank on their listing on the Cambodia Exchange
- Advised Korean financial companies on the issuance of domestic and international CBs, BWs and FRNs for a number Korean listed companies
- Advised on overseas issuance of CBs and BWs in the US and Euro markets
- Advised SAEHWA IMC, CHINHUNG INTERNATIONAL, STX, Borneo Furniture on their response to a corporate examination by the Securities Exchange
- Advised WI, KD, Barun Electronics, Deco&E, SBW Life Science, MP Group, GD, Mason Capital Corporation, Kyung Nam Pharm, Good People, and Kossen on their response to a corporate examination by the KOSDAQ market
- Advised LS Cable & System, a Korean SPC of a Vietnamese company, and Hwaseung Enterprise (a Korean SPC of a Vietnamese company) on their listing on the securities market at the Korea Exchange
- Advised Nanogen, the largest biosimilar company in Vietnam on the listing on the KOSDAQ market
- Advised Prestige BioPharma, a Singapore-based biosimilar company, on the listing on the KOSDAQ market
- Advised NeoImmuneTech, a US company, on the establishment of the disclosure system and maintenance of the listing
- Advised US companies including NewPride Corporation, OncoPep, Exbon, and Bankcard Service on the listing on the KOSDAQ market
- Advised Fast Future Brands, an Australian company, on the listing on the securities market
- Advised KOLAO Holdings (SPC in the Cayman Islands), a subsidiary of KOLAO Group, one of the biggest private companies in Laos, on the listing on the KOSPI market
- Advised Japanese companies including Office 24, Food Discovery Co. Inc., and Power Technology Inc. on the listing on the KOSDAQ market
- Advised Qingxiang Jiancai (an Cayman Islands company), Sino Polymer (a Cayman Islands holding company), Aju Gwangjeon (a Hong Kong holding company), China Green Packaging (a Hong Kong holding company), a Chinese subsidiary of a Korean listed company, and overseas Korean-owned companies located in Shanghai and Yantai on their listing on the securities and KOSDAQ markets
- Advised Essex Bio, a Hong Kong company, on the 2nd listing of the KOSDAQ market
- Advised Indonesian companies including Grantec, LEJEL Home Shopping, and Gold Code on their listing on the KOSDAQ market
- Advised Intercos Asia, an Italian company, on the listing of the KOSPI market
- Advisor to the Korea Exchange (current)
- Advisor to the Korea Securities Depository (current)
- Advisor to the PEF GP Council (current)
- Advisor to the Korean Financial Supervisory Service (2004-2009, 2013-2017)
- Advisor to the Korea Financial Investment Association (2002-2012)
- Participation in the enactment of the Financial Investment Services and Capital Market Act (2007) and TF for revision (2014)
- Participation in Korea Exchange’s IPO Guidebook TF (2011-2015)
- Legal research on legislations regarding Indonesia/Vietnam Companies’ Listing on the Korea Exchange (2016)
[Advised on IPO of Korean Companies]
[Overseas IPO of Korean Companies, Public Offering of Overseas Securities and Capital Market]
[Advised on response to an examination for De-listing]
[IPO of Foreign Companies in Korea]
[Advisory service to Competent Authorities in Capital Markets]
